Talking oncology targets (EGFR, FLT3, B7H4 and more) with Cullinan Oncology
- blonca9
- Jun 7, 2023
- 1 min read
Updated: Jun 1, 2024
Cullinan Oncology CEO Nadim Ahmed walks us through the oncology targets the company is focused on and discusses recent ASCO data.